Locate Bio raises £9.2m to progress LDGraft clinical study
Locate Bio – the pioneering orthobiologics company which is backed by Mercia, has completed an oversubscribed £9.2m funding round backed by both new investors and existing investors, Mercia and BGF. The proceeds will fund a clinical study of LDGraft, a bone graft substitute for spinal fusion. This funding and the clinical trial known as RESTORE